News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Eisai Inc. Divests Clinical Diagnostics Supply Biz for $183 Million
November 30, 2015
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Eisai will sell its clinical diagnostics business – EIDIA Co. Ltd - to Sekisui Chemical for JPY 22.4bn ($183m).
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Asia
Eisai Inc.
MORE ON THIS TOPIC
Antibody-drug conjugate (ADC)
Takeda Bets up to $11.4B for Three Innovent ADCs
October 22, 2025
·
2 min read
·
Tristan Manalac
Podcast
Novo Board Upended, ESMO Excitement, FDA Awards, Replimune’s U-Turn
October 22, 2025
·
1 min read
·
Heather McKenzie
Mergers & acquisitions
Rumors of Eli Lilly Buyout Send Nektar’s Shares Spiking
October 20, 2025
·
2 min read
·
Tristan Manalac
Antibody-drug conjugate (ADC)
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet
October 17, 2025
·
2 min read
·
Tristan Manalac
